DTIL Precision BioSciences, Inc. - Common Stock
$7.61
价格 · 八月 18, 2026
截至...的财报数据 八月 6, 2026
52周区间
$4–$10
67% of range
分析师评级
STRONG BUY
11 analysts
目标价
$29
+286% upside
P/E (TTM)
-2.3
ROE
-72.4%
净利润率
-133.4%
DTIL 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$7.61
市值
$197M
P/E (TTM)
-2.3
每股收益 (TTM)
$-3.56
营收 (TTM)
$34M
股息收益率
—
ROE
-72.4%
负债/权益
—
52周区间
$4 – $10
DTIL 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$34M
2019-12-31
→
2025-12-31
EPS
$-3.56
2021-12-31
→
2025-12-31
自由现金流
$-66M
2019-12-31
→
2025-12-31
利润率
-133.4%
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
DTIL
同行中位数
P/E (TTM)
-2.3
1.2
P/S (TTM) (市销率 (TTM))
5.7
6.3
P/B (市净率)
2.1
1.6
Price / FCF (股价/自由现金流)
-3.0
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
DTIL
同行中位数
Operating Margin (营业利润率)
-152.2%
—
Net Profit Margin (净利润率)
-133.4%
-312.6%
ROA
-31.4%
-56.8%
ROE
-72.4%
-83.3%
ROIC
-56.5%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
DTIL
同行中位数
Current Ratio (流动比率)
13.3
8.5
Quick Ratio (速动比率)
13.0
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
DTIL
同行中位数
Revenue YoY (营收同比增长)
-50.1%
—
Revenue CAGR 3Y (营收3年复合年增长率)
10.9%
—
Revenue CAGR 5Y (营收5年复合年增长率)
7.1%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
DTIL
同行中位数
DTIL 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
11 位分析师
- 强烈买入 5 45.5%
- 买入 5 45.5%
- 持有 1 9.1%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
5 位分析师 · 2026-08-16
中位数
$20.00
平均值
$29.40
← 低于所有目标
$7.61
最低
$18.00
最高
$60.00
中位数目标
$20.00
+162.8%
平均目标
$29.40
+286.3%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-0.07%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $-1.26 | $-0.81 | -0.45% |
| 2026年3月31日 | $-0.75 | $-0.67 | -0.08% |
| 2025年12月31日 | $1.05 | $-0.55 | 1.6% |
| 2025年9月30日 | $-1.84 | $-1.37 | -0.47% |
| 2025年6月30日 | $-2.13 | $-1.60 | -0.53% |
| 2025年3月31日 | $-2.21 | $-1.75 | -0.46% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| DTIL | $100M | -1.2 | -50.1% | -133.4% | -72.4% | — |
| IVVD | $697M | -8.2 | 110.5% | -98.2% | -36.9% | — |
| TNXP | $200M | -1.1 | 29.8% | -946.2% | -60.0% | — |
| WHWK | $114M | -7.3 | -72.5% | -288.3% | -13.4% | — |
| PEPG | $448M | -3.1 | — | — | -82.0% | — |
| KROS | $398M | 8.9 | — | 35.7% | 17.2% | — |
| CRBP | $143M | -1.4 | — | — | -60.8% | — |
| KRRO | $75M | -0.6 | 181.5% | -1834.5% | -140.8% | — |
| ABOS | $128M | -1.1 | — | — | -129.4% | — |
| CUE | $29M | -1.1 | 195.8% | -96.9% | -119.3% | — |
| VYGR | $232M | -1.9 | -49.5% | -296.5% | -54.4% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 16
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $34M | $69M | $49M | $25M | $116M | $24M | $22M | |
| R&D Expense | $54M | $60M | $53M | $46M | $115M | $98M | $82M | |
| SG&A Expense | $32M | $35M | $39M | $41M | $40M | $36M | $27M | |
| Operating Expenses | $86M | $95M | $92M | $87M | $155M | $134M | $109M | |
| Operating Income | $-52M | $-26M | $-44M | $-62M | $-39M | $-110M | $-87M | |
| Interest Expense | · | $2M | $2M | $1M | $132.0K | · | $182.0K | |
| Interest Income | · | · | · | · | $208.0K | $822.0K | $4M | |
| Other Non-op | $6M | $33M | $1M | $-11M | $9M | $822.0K | $-6M | |
| Pretax Income | $-46M | $7M | · | · | · | · | · | |
| Income Tax | $0 | $0 | · | · | · | $23.0K | · | |
| Net Income | $-46M | $7M | $-61M | $-112M | $-31M | $-109M | $-93M | |
| EPS (Basic) | $-3.56 | $1.05 | $-15.96 | $-38.10 | $-0.52 | · | · | |
| EPS (Diluted) | $-3.56 | $1.04 | $-15.96 | $-38.10 | $-0.52 | · | · | |
| Shares (Basic) | 12,826,078 | 6,832,982 | 3,841,405 | 2,929,873 | 58,688,102 | · | · | |
| Shares (Diluted) | 12,826,078 | 6,883,911 | 3,841,405 | 2,929,873 | 58,688,102 | · | · | |
| EBITDA | $-52M | $-26M | $-44M | $-100M | $-39M | $-110M | $-87M |
资产负债表 25
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $111M | $86M | $117M | $190M | $144M | $90M | $181M | |
| Short-term Investments | $5M | $413.0K | · | · | · | · | · | |
| Receivables | $0 | $229.0K | $901.0K | $720.0K | $488.0K | $10M | $965.0K | |
| Prepaid Expense | $3M | $6M | $6M | $6M | $17M | $6M | $9M | |
| Other Current Assets | $45.0K | $369.0K | $419.0K | $1M | $169.0K | $4.0K | $2M | |
| Current Assets | $119M | $95M | $136M | $199M | $162M | $106M | $194M | |
| PP&E (Net) | $1M | $3M | $6M | $12M | $25M | $35M | $40M | |
| PP&E (Gross) | $30M | $31M | $32M | $34M | $49M | $54M | $50M | |
| Accum. Depreciation | $29M | $28M | $25M | $22M | $24M | $19M | $11M | |
| Intangibles | $1M | $622.0K | $400.0K | $731.0K | $2M | $1M | $1M | |
| Other Non-current Assets | $206.0K | $221.0K | $225.0K | $226.0K | $5M | $2M | $558.0K | |
| Total Assets | $154M | $136M | $160M | $238M | $211M | $150M | $235M | |
| Accounts Payable | $296.0K | $1M | $3M | $653.0K | $1M | $792.0K | $2M | |
| Current Liabilities | $9M | $15M | $50M | $60M | $36M | $43M | $27M | |
| Capital Leases | $5M | $6M | $8M | $1M | $5M | $9M | · | |
| Deferred Tax | $1M | $2M | $3M | $1M | $2M | $2M | $1M | |
| Other Non-current Liabilities | $259.0K | $194.0K | $128.0K | $201.0K | $44.0K | $392.0K | · | |
| Total Liabilities | $62M | $80M | $141M | $178M | $120M | $106M | $97M | |
| Long-term Debt | · | · | · | $22M | $2M | · | · | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | · | · | · | |
| Retained Earnings | $-528M | $-482M | $-490M | $-428M | $-317M | $-286M | $-177M | |
| Treasury Stock | $952.0K | $952.0K | $952.0K | $952.0K | $952.0K | $952.0K | $952.0K | |
| Stockholders' Equity | $92M | $56M | $19M | $60M | $91M | $44M | $138M | |
| Liabilities + Equity | $154M | $136M | $160M | $238M | $211M | $150M | $235M | |
| Shares Outstanding | 24,088,425 | 8,229,730 | 4,191,053 | 3,698,674 | 60,902,105 | 52,692,652 | 51,155,236 |
现金流 13
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $3M | $7M | $8M | $9M | $9M | $5M | |
| Stock-based Comp | $10M | $13M | $14M | $19M | $17M | $14M | $9M | |
| Amort. of Intangibles | $100.0K | $100.0K | $100.0K | $100.0K | · | · | $100.0K | |
| Operating Cash Flow | $-66M | $-58M | $-84M | $-46M | $-11M | $-87M | $-71M | |
| CapEx | $85.0K | $250.0K | $2M | $3M | $5M | $5M | $25M | |
| Investing Cash Flow | $-634.0K | $-215.0K | $6M | $-3M | $-6M | $-5M | $-25M | |
| Net Debt Issued | · | · | · | · | $-2M | · | · | |
| Stock Issued | · | · | $5M | $49M | $25M | · | · | |
| Net Stock Activity | · | · | $5M | $49M | $25M | · | · | |
| Financing Cash Flow | $95M | $50M | $5M | $95M | $71M | $1M | $173M | |
| Net Change in Cash | $29M | $-8M | $-73M | $46M | $54M | $-91M | $78M | |
| Taxes Paid | $0 | · | · | · | · | · | · | |
| Free Cash Flow | $-66M | $-59M | $-86M | $-49M | $-16M | $-92M | $-96M |
盈利能力 7
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -152.2% | -38.1% | -89.8% | -399.9% | -34.1% | -452.2% | -8.2% | |
| Net Margin | -133.4% | 10.4% | -125.8% | -444.8% | -26.5% | -448.9% | -8.7% | |
| Pretax Margin | -133.4% | · | · | · | · | · | · | |
| EBITDA Margin | -152.2% | -38.1% | -89.8% | -399.9% | -34.1% | -452.2% | -8.2% | |
| ROA | -31.4% | 4.8% | -30.8% | -49.6% | -16.9% | -56.6% | -49.7% | |
| ROE | -72.4% | 11.8% | -255.9% | -154.2% | -31.8% | -201.4% | -63.2% | |
| ROIC | -56.5% | · | · | · | · | · | · |
流动性与偿付能力 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 13.3 | 6.3 | 2.7 | 3.3 | 4.5 | 2.5 | 7.2 | |
| Quick Ratio | 13.0 | 5.8 | 2.4 | 3.2 | 4.0 | 2.3 | 6.8 | |
| Interest Coverage | · | -14.7 | -19.6 | -90.3 | -298.5 | · | -479.1 |
效率 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.5 | 0.2 | 0.1 | 0.6 | 0.1 | 5.7 | |
| Receivables Turnover | 299.2 | 121.6 | 60.1 | 41.6 | 22.0 | 4.4 | 1438.2 |
增长率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -50.1% | 41.0% | 94.2% | -78.3% | 375.7% | · | · | |
| Revenue CAGR 3Y | 10.9% | -15.9% | 26.1% | · | · | · | · | |
| Revenue CAGR 5Y | 7.1% | · | · | · | · | · | · |
估值 (TTM) 10
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $34M | $69M | $49M | $25M | $116M | $24M | $22M | |
| Net Income TTM | $-46M | $7M | $-61M | $-112M | $-31M | $-109M | $-93M | |
| Market Cap | $100M | $31M | $46M | $3.96B | $13.52B | $13.18B | $21.32B | |
| P/E | -1.2 | 3.7 | -0.7 | -0.9 | -426.9 | · | · | |
| P/S | 2.9 | 0.5 | 0.9 | 157.8 | 117.0 | 542.9 | 958.6 | |
| P/B | 1.1 | 0.6 | 2.4 | 65.6 | 148.3 | 296.8 | 154.1 | |
| P / Tangible Book | 1.1 | 0.6 | 2.5 | 66.4 | 151.7 | 306.2 | · | |
| P / Cash Flow | -1.5 | -0.5 | -0.5 | -86.6 | -1245.8 | -150.9 | -300.2 | |
| P / FCF | -1.5 | -0.5 | -0.5 | -80.7 | -850.0 | -142.7 | -222.8 | |
| Earnings Yield | -85.6% | 27.3% | -145.8% | -106.7% | -0.23% | · | · |
损益表 13
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $11M | $34M | $13.0K | $18.0K | $29.0K | $638.0K | $576.0K | $50M | $18M | $7M | $13M | $20M | $9M | $11M | $7M | |
| R&D Expense | $12M | $13M | $14M | $13M | $13M | $14M | $16M | $13M | $17M | $13M | $13M | $16M | $13M | $11M | $-9M | $12M | |
| SG&A Expense | $7M | $7M | $7M | $7M | $9M | $9M | $10M | $9M | $9M | $8M | $9M | $10M | $10M | $11M | $10M | $10M | |
| Operating Expenses | $19M | $20M | $22M | $21M | $22M | $22M | $25M | $22M | $26M | $22M | $22M | $25M | $23M | $22M | $1M | $22M | |
| Operating Income | $-19M | $-9M | $13M | $-21M | $-22M | $-22M | $-25M | $-21M | $24M | $-4M | $-15M | $-12M | $-3M | $-13M | $9M | $-15M | |
| Interest Expense | · | · | · | · | · | $354.0K | · | $256.0K | $560.0K | $574.0K | $579.0K | $576.0K | $553.0K | $522.0K | $486.0K | $405.0K | |
| Other Non-op | $-13M | $-9M | $7M | $-1M | $-2M | $2M | $7M | $5M | $9M | $13M | $1M | $253.0K | $96.0K | $-596.0K | $-7M | $-1M | |
| Net Income | $-33M | $-18M | $20M | $-22M | $-24M | $-21M | $-18M | $-16M | $33M | $9M | $-16M | $-8M | $-12M | $-25M | $-28M | $-24M | |
| EPS (Basic) | $-1.26 | $-0.75 | $2.62 | $-1.84 | $-2.13 | $-2.21 | $-3.10 | $-2.25 | $4.70 | $1.70 | $-3.98 | $-2.10 | $-3.13 | $-6.75 | $-36.96 | $-0.22 | |
| EPS (Diluted) | $-1.26 | $-0.75 | $2.62 | $-1.84 | $-2.13 | $-2.21 | $-3.08 | $-2.25 | $4.67 | $1.70 | $-3.98 | $-2.10 | $-3.13 | $-6.75 | $-36.96 | $-0.22 | |
| Shares (Basic) | 25,856,628 | 24,634,443 | -19,330,534 | 11,818,145 | 11,046,401 | 9,292,066 | -12,481,849 | 7,287,173 | 6,966,680 | 5,060,978 | -7,510,472 | 3,838,900 | 3,803,083 | 3,709,894 | -236,905,786 | 110,849,196 | |
| Shares (Diluted) | 25,856,628 | 24,634,443 | -19,330,534 | 11,818,145 | 11,046,401 | 9,292,066 | -12,478,298 | 7,287,173 | 7,011,630 | 5,063,406 | -7,510,472 | 3,838,900 | 3,803,083 | 3,709,894 | -236,905,786 | 110,849,196 | |
| EBITDA | $-19M | $-9M | · | $-21M | $-22M | $-22M | · | $-21M | $24M | $-4M | · | $-12M | $-12M | $-24M | · | $-23M |
资产负债表 25
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $86M | $99M | $111M | $45M | $62M | $77M | $86M | $99M | $124M | $138M | $117M | $122M | $138M | $158M | $190M | $212M | |
| Short-term Investments | $1M | $2M | $5M | $0 | $0 | · | $413.0K | $2M | · | · | · | · | · | · | · | · | |
| Receivables | $0 | $4M | $0 | $4.0K | $0 | $4.0K | $229.0K | $188.0K | $207.0K | $390.0K | $901.0K | $4M | $652.0K | $694.0K | $720.0K | $715.0K | |
| Prepaid Expense | $4M | $4M | $3M | $6M | $7M | $5M | $6M | $7M | $6M | $9M | $6M | $8M | $9M | $8M | $6M | $12M | |
| Other Current Assets | $5.0K | $6.0K | $45.0K | $848.0K | $427.0K | $116.0K | $369.0K | $471.0K | $790.0K | $128.0K | $419.0K | $349.0K | $503.0K | $2M | $1M | $307.0K | |
| Current Assets | $92M | $109M | $119M | $52M | $70M | $82M | $95M | $111M | $144M | $161M | $136M | $146M | $148M | $169M | $199M | $225M | |
| PP&E (Net) | $964.0K | $1M | $1M | $2M | $2M | $3M | $3M | $4M | $4M | $5M | $6M | $9M | $18M | $19M | $12M | $22M | |
| PP&E (Gross) | · | · | $30M | · | · | · | $31M | · | · | · | $32M | · | · | · | $34M | · | |
| Accum. Depreciation | · | · | $29M | · | · | · | $28M | · | · | · | $25M | · | · | · | $22M | · | |
| Intangibles | $1M | $1M | $1M | $985.0K | $605.0K | $607.0K | $622.0K | $388.0K | $375.0K | $386.0K | $400.0K | $977.0K | $2M | $2M | $731.0K | $2M | |
| Other Non-current Assets | $126.0K | $203.0K | $206.0K | $200.0K | $208.0K | $215.0K | $221.0K | $224.0K | $234.0K | $238.0K | $225.0K | $234.0K | $619.0K | $3M | $226.0K | $10M | |
| Total Assets | $126M | $144M | $154M | $94M | $109M | $124M | $136M | $153M | $166M | $185M | $160M | $164M | $182M | $205M | $238M | $272M | |
| Accounts Payable | $828.0K | $944.0K | $296.0K | $1M | $1M | $924.0K | $1M | $958.0K | $1M | $1M | $3M | $531.0K | $781.0K | $701.0K | $653.0K | $1M | |
| Current Liabilities | $7M | $8M | $9M | $15M | $14M | $12M | $15M | $12M | $33M | $33M | $50M | $51M | $56M | $47M | $60M | $61M | |
| Capital Leases | $4M | $4M | $5M | $5M | $6M | $6M | $6M | $7M | $7M | $7M | $8M | · | $3M | $2M | $1M | $3M | |
| Deferred Tax | · | · | $1M | · | · | · | $2M | · | · | · | $3M | · | · | · | $1M | · | |
| Other Non-current Liabilities | $301.0K | $324.0K | $259.0K | $227.0K | $200.0K | $197.0K | $194.0K | $188.0K | · | · | $128.0K | $766.0K | · | $199.0K | $201.0K | $217.0K | |
| Total Liabilities | $81M | $68M | $62M | $77M | $75M | $75M | $80M | $88M | $91M | $148M | $141M | $135M | $148M | $164M | $178M | $187M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $22M | $22M | $22M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | |
| Retained Earnings | $-579M | $-547M | $-528M | $-548M | $-527M | $-503M | $-482M | $-465M | $-448M | $-481M | $-490M | $-473M | $-465M | $-453M | $-428M | $-400M | |
| Treasury Stock | $952.0K | $952.0K | $952.0K | $952.0K | $952.0K | $952.0K | $952.0K | $952.0K | $952.0K | $952.0K | $952.0K | $952.0K | $952.0K | $952.0K | $952.0K | $952.0K | |
| Stockholders' Equity | $45M | $76M | $92M | $17M | $34M | $49M | $56M | $65M | $75M | $37M | $19M | $29M | $34M | $40M | $60M | $84M | |
| Liabilities + Equity | $126M | $144M | $154M | $94M | $109M | $124M | $136M | $153M | $166M | $185M | $160M | $164M | $182M | $205M | $238M | $272M | |
| Shares Outstanding | 26,433,558 | 25,805,898 | 24,088,425 | 12,082,665 | 11,636,981 | 10,548,852 | 8,202,715 | 7,480,521 | 7,123,370 | 6,916,239 | 4,164,038 | 115,680,008 | 115,070,517 | 112,339,421 | 3,698,674 | 110,934,747 |
现金流 10
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $253.0K | $299.0K | $345.0K | $350.0K | $378.0K | $395.0K | $454.0K | $715.0K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | |
| Stock-based Comp | $2M | $2M | $2M | $2M | $3M | $3M | $4M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $5M | $5M | |
| Operating Cash Flow | $-13M | $-12M | $-11M | $-15M | $-20M | $-19M | $-19M | $-6M | $-15M | $-19M | $-8M | $-23M | $-21M | $-31M | $-22M | $29M | |
| CapEx | $0 | $18.0K | $19.0K | $0 | $2.0K | $64.0K | $97.0K | $39.0K | $28.0K | $86.0K | $-26.0K | $386.0K | $1M | $521.0K | $632.0K | $1M | |
| Investing Cash Flow | $1.0K | $-114.0K | $-325.0K | $17.0K | $-12.0K | $-314.0K | $-97.0K | $-64.0K | $-28.0K | $-26.0K | $42.0K | $8M | $-1M | $-721.0K | $-632.0K | $-1M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | $-138.0K | $2M | $445.0K | $0 | $-190.0K | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $445.0K | · | · | |
| Financing Cash Flow | $0 | $745.0K | $78M | $2M | $5M | $11M | $6M | $4M | $702.0K | $40M | $3M | $-34.0K | $2M | $741.0K | $0 | $-180.0K | |
| Net Change in Cash | $-13M | $-11M | $66M | $-14M | $-15M | $-9M | $-13M | $-2M | $-14M | $21M | $-6M | $-16M | $-20M | $-31M | $-22M | $28M | |
| Free Cash Flow | · | $-12M | · | · | · | $-19M | · | · | · | $-19M | · | · | · | $-32M | · | · |
盈利能力 5
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -83.7% | · | -158976.9% | -121538.9% | -76248.3% | · | -3693.6% | 48.4% | -23.8% | · | -94.2% | -60.6% | -278.6% | · | -311.4% | |
| Net Margin | · | -170.2% | · | -167476.9% | -130666.7% | -70913.8% | · | -2851.6% | 65.6% | 48.8% | · | -61.6% | -60.1% | -285.4% | · | -325.2% | |
| EBITDA Margin | · | -83.7% | · | -158976.9% | -121538.9% | -76248.3% | · | -3693.6% | 48.4% | -23.8% | · | -94.2% | -60.6% | -278.6% | · | -311.4% | |
| ROA | -27.8% | -13.8% | · | -17.6% | -17.1% | -13.3% | · | -10.3% | 18.9% | 4.4% | · | -3.7% | -5.0% | -13.0% | · | -9.6% | |
| ROE | -82.3% | -29.4% | · | -53.4% | -43.2% | -47.5% | · | -35.0% | 60.2% | 22.2% | · | -14.2% | -17.3% | -45.6% | · | -25.8% |
流动性与偿付能力 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.8 | 14.0 | · | 3.4 | 5.2 | 6.6 | · | 9.2 | 4.4 | 4.8 | · | 2.9 | 2.6 | 3.6 | · | 3.7 | |
| Quick Ratio | 12.3 | 13.6 | · | 3.0 | 4.6 | 6.2 | · | 8.5 | 3.8 | 4.1 | · | 2.5 | 2.5 | 3.4 | · | 3.5 | |
| Interest Coverage | · | · | · | · | · | -62.5 | · | -83.1 | 43.1 | -7.3 | · | -21.5 | -21.7 | -46.9 | · | -56.6 |
效率 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.3 | 0.1 | · | 0.1 | 0.1 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | 5.4 | · | 0.1 | 0.2 | 0.1 | · | 0.3 | 116.2 | 32.4 | · | 6.2 | 0.8 | 14.9 | · | 12.2 |
估值 (TTM) 10
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $11M | $11M | · | $636.0K | $51M | $68M | · | $81M | $100M | $59M | · | $49M | $40M | $23M | · | $39M | |
| Net Income TTM | $-96M | $-84M | · | $-82M | $-28M | $4M | · | $17M | $21M | $-36M | · | $-69M | $-92M | $-108M | · | $-94M | |
| Market Cap | $208M | $142M | · | $67M | $49M | $50M | · | $67M | $69M | $94M | · | $1.18B | $1.82B | $2.54B | · | $4.33B | |
| P/E | -1.3 | -0.8 | · | -0.7 | -2.2 | 2.5 | · | 4.4 | 8.5 | -1.3 | · | -0.8 | -1.5 | -2.9 | · | -29.3 | |
| P/S | 19.1 | 13.0 | · | 104.9 | 1.0 | 0.7 | · | 0.8 | 0.7 | 1.6 | · | 24.1 | 45.7 | 109.2 | · | 112.3 | |
| P/B | 4.6 | 1.9 | · | 4.0 | 1.4 | 1.0 | · | 1.0 | 0.9 | 2.5 | · | 40.7 | 53.3 | 63.2 | · | 51.3 | |
| P / Tangible Book | 4.7 | 1.9 | · | 4.3 | 1.5 | 1.0 | · | 1.0 | 0.9 | 2.5 | · | 42.1 | 55.9 | 65.7 | · | 52.5 | |
| P / Cash Flow | · | -11.9 | · | · | · | -2.6 | · | · | · | -4.9 | · | · | · | -80.8 | · | · | |
| P / FCF | · | -11.9 | · | · | · | -2.6 | · | · | · | -4.9 | · | · | · | -79.4 | · | · | |
| Earnings Yield | -76.1% | -126.0% | · | -152.7% | -45.7% | 40.0% | · | 22.5% | 11.7% | -75.8% | · | -119.3% | -66.9% | -34.9% | · | -3.4% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $34M | $69M | $49M | $25M | $116M |
| 营业利润率 % | -152.2% | -38.1% | -89.8% | -399.9% | -34.1% |
| 净收入 | $-46M | $7M | $-61M | $-112M | $-31M |
| 稀释后每股收益 (EPS) | $-3.56 | $1.04 | $-15.96 | $-38.10 | $-0.52 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 流动比率 | 13.3 | 6.3 | 2.7 | 3.3 | 4.5 |
| 速动比率 | 13.0 | 5.8 | 2.4 | 3.2 | 4.0 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $-66M | $-59M | $-86M | $-49M | $-16M |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 100 家申报者 · $125.1M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 35 (+15 与上一季度对比) | 12 (+2 与上一季度对比) | 26 (+9 与上一季度对比) | 16 (0 与上一季度对比) | +1.6M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
公司内部人士 22 位内幕人士 · 10 位高管 · 11 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Michael Amoroso | President and CEO | 2026年6月1日 A | — | 0 | 0 | $0 |
| Fayaz Khazi | CEO of Elo Life Systems | 2021年6月7日 A | — | 0 | 0 | $0 |
| John Alexander Kelly | Chief Financial Officer | 2026年6月1日 A | — | 0 | 0 | $0 |
| Abid Ansari | Chief Financial Officer | 2020年6月15日 M | 144401 | 0 | 0 | $0 |
| Dario Scimeca | General Counsel and Secretary | 2026年6月1日 A | — | 0 | 0 | $0 |
| Jefferson J. Smith | Chief Research Officer | 2026年6月1日 A | — | 0 | 0 | $0 |
| Alan List | Chief Medical Officer | 2024年5月1日 M | 4488 | 0 | 0 | $0 |
| Shane Barton | VP & Corporate Controller | 2023年6月7日 M | 27502 | 0 | 0 | $0 |
| Derek Jantz | Chief Scientific Officer | 2022年6月7日 M | 4055174 | 0 | 0 | $0 |
| Christopher Heery | Chief Medical Officer | 2020年6月8日 A | 2485 | 0 | 0 | $0 |
| Shari Lisa Pire | 董事 | 2026年6月3日 A | — | 0 | 0 | $0 |
| Stanley Frankel | 董事 | 2026年6月3日 A | — | 0 | 0 | $0 |
| Kevin Buehler | 董事 | 2026年6月3日 A | — | 0 | 0 | $0 |
| Melinda Brown | 董事 | 2026年6月3日 A | — | 0 | 0 | $0 |
| Geno J Germano | 董事 | 2026年6月3日 A | — | 0 | 0 | $0 |
| Samuel C. Wadsworth | 董事 | 2024年6月4日 A | 4202 | 0 | 0 | $0 |
| Raymond F Schinazi | 董事 | 2022年5月10日 A | 93048 | 0 | 0 | $0 |
| Shalini Sharp | 董事 | 2021年5月10日 A | — | 0 | 0 | $0 |
| Tony Dung Ling Yao | 董事 | 2019年4月3日 P | 158003 | 0 | 0 | $0 |
| David S. Thomson | — | 2021年6月23日 M | 111513 | 0 | 0 | $0 |
| Matthew R. Kane | — | 2020年8月21日 A | 2013597 | 0 | 0 | $0 |
| FMR LLC | — | 2019年4月1日 C | 3738248 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 1 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| venBio Global Strategic Fund, L.P., venBio Global Strategic GP, L.P., venBio Global Strategic GP, Ltd., Robert Adelman, Corey Goodman ×4 申报 | 2020年7月9日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 11 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trus... | 0.53% | 16044 SH | 2026年8月8日 | 每日 |
| IWC · iShares Trust | 0.04% | 80560 SH | 2026年8月8日 | 每日 |
| IWN · iShares Trust | 0.01% | 218245 SH | 2026年8月8日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 138702 SH | 2026年8月8日 | 每日 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.01% | 20860 SH | 2026年8月8日 | 每日 |
| IWM · iShares Trust | 0.01% | 550462 SH | 2026年8月8日 | 每日 |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.00% | 10604 NS | 2026年5月31日 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.00% | 9014 NS | 2026年4月30日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 312368 SH | 2026年8月8日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 778139 SH | 2026年8月8日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 2220 SH | 2026年8月8日 | 每日 |